RE:RE:A little decision analysis I agree on the " values" of the last corporation updates.
Specifically the Pancreatic cancer results. They afterall were discussed in deatai with the Kol key opinion leaders, telecfonference.
Although quite medical in context, quite well explained & very enthusiastic.
Then can A.N. Update giving " further encouraging signs of Pelareorep as a cancer co- therapy"
now"................
All politics, speculation & even business models aside.
The only reason ONC was incorporated, was to get Pela approved for market as a cancer treatment.
Once again back to the science. Does it work or not.
If it does, the business end will fall naturally into place.
LIF not, no discussions further.
So?
Based on existing data & date points, all arrows point to June as the latest, with mid March being the earliest as to revealing Aware-1, bracelet & the very silent Pancreatic cancer Goblet & additional G.I. Cancers.
With an almost instant FDA fast track designation for Pelareorep ( pancreatic cancer) alongside Roche Tecentriq; I view that as very positive scientific evidence.
The idea that Onc is a scam is childish nonsense. There are too many eyes on not only Onc as a company, but the product itself. Pelareorep is presently in no fewer than a dozen locations, with mutiple.PHDs analyzing, reviewing etc etc.
SOLTI for example. Global leader in breast cancer research. They not only ran the Aware-1 trial, but have a representative on Onc scientific advisory board.
Have a great week all.